Narayana Hrudayalaya Share Price
Sector: Healthcare Facilities
1205.35 +3.35 (0.28%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1190.3
Today’s High
1222.7
52 Week Low
972.05
52 Week High
1445.05
1204.75 +3.50 (0.29%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1190.2
Today’s High
1222.65
52 Week Low
973.4
52 Week High
1444.9
Key Metrics
- Market Cap (In Cr) 24290.74
- Beta 0.85
- Div. Yield (%) 0.33
- P/B 8.42
- TTM P/E 33.03
- Peg Ratio 11.61
- Sector P/E 27.33
- D/E 0.56
- Open Price 1214.85
- Prev Close 1202
Narayana Hrudayalaya Analysis
Price Analysis
-
1 Week-2.57%
-
3 Months-6.43%
-
6 Month0.26%
-
YTD-0.06%
-
1 Year22.01%
Risk Meter
- 32% Low risk
- 32% Moderate risk
- 32% Balanced Risk
- 32% High risk
- 32% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 3
- 3
- 3
- 3
- Hold
- 1
- 1
- 1
- 0
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 6
- 6
- 6
- 5
Narayana Hrudayalaya News
Stocks to buy: Narayana Hrudayalaya, Zen Technologies, among top stock picks
3 min read . 04 Mar 2024Narayana Hrudayalaya Q3 FY24 Results Live : profit rise by 22.27% YOY
1 min read . 16 Feb 2024Q3 Results Today: M&M, NMDC, Muthoot Finance, ABFRL to post earnings on Feb 14
2 min read . 14 Feb 2024Narayana Hrudayalaya Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 5018.25
- Selling/ General/ Admin Expenses Total
- 1004.3
- Depreciation/ Amortization
- 242.14
- Other Operating Expenses Total
- 902.95
- Total Operating Expense
- 4108.03
- Operating Income
- 910.22
- Net Income Before Taxes
- 888.53
- Net Income
- 789.26
- Diluted Normalized EPS
- 38.86
- Period
- 2024
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 129.63
- Period
- 2024
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023
- Total Revenue
- 4524.76
- Selling/ General/ Admin Expenses Total
- 1259.72
- Depreciation/ Amortization
- 210.04
- Other Operating Expenses Total
- 4.28
- Total Operating Expense
- 3746.5
- Operating Income
- 778.26
- Net Income Before Taxes
- 751.58
- Net Income
- 606.25
- Diluted Normalized EPS
- 29.48
- Period
- 2023
- Total Assets
- 4162.09
- Total Liabilities
- 2030.71
- Total Equity
- 2131.38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2023
- Cashfrom Operating Activities
- 1084.56
- Cashfrom Investing Activities
- -1174.1
- Cashfrom Financing Activities
- 87.74
- Net Changein Cash
- -3.93
- Period
- 2022
- Total Revenue
- 3701.32
- Selling/ General/ Admin Expenses Total
- 1045.24
- Depreciation/ Amortization
- 183.48
- Other Operating Expenses Total
- 2.03
- Total Operating Expense
- 3220.1
- Operating Income
- 481.22
- Net Income Before Taxes
- 429.78
- Net Income
- 341.93
- Diluted Normalized EPS
- 16.96
- Period
- 2022
- Total Assets
- 3130.53
- Total Liabilities
- 1641.9
- Total Equity
- 1488.64
- Tangible Book Valueper Share Common Eq
- 67.53
- Period
- 2022
- Cashfrom Operating Activities
- 485.02
- Cashfrom Investing Activities
- -266.91
- Cashfrom Financing Activities
- -158.95
- Net Changein Cash
- 59.02
- Period
- 2021
- Total Revenue
- 2582.35
- Selling/ General/ Admin Expenses Total
- 851.74
- Depreciation/ Amortization
- 183.53
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 2577.06
- Operating Income
- 5.29
- Net Income Before Taxes
- -56.07
- Net Income
- -14.3
- Diluted Normalized EPS
- -0.54
- Period
- 2021
- Total Assets
- 2770.02
- Total Liabilities
- 1649.74
- Total Equity
- 1120.28
- Tangible Book Valueper Share Common Eq
- 49.02
- Period
- 2021
- Cashfrom Operating Activities
- 309.05
- Cashfrom Investing Activities
- -112.99
- Cashfrom Financing Activities
- -198.43
- Net Changein Cash
- -2.34
- Period
- 2020
- Total Revenue
- 3127.81
- Selling/ General/ Admin Expenses Total
- 968.56
- Depreciation/ Amortization
- 185.8
- Other Operating Expenses Total
- 1.39
- Total Operating Expense
- 2900.02
- Operating Income
- 227.79
- Net Income Before Taxes
- 161.3
- Net Income
- 118.92
- Diluted Normalized EPS
- 6.5
- Period
- 2020
- Total Assets
- 2891.06
- Total Liabilities
- 1755.1
- Total Equity
- 1135.96
- Tangible Book Valueper Share Common Eq
- 49.23
- Period
- 2020
- Cashfrom Operating Activities
- 443.34
- Cashfrom Investing Activities
- -188.54
- Cashfrom Financing Activities
- -246.94
- Net Changein Cash
- 7.49
- Period
- 2019
- Total Revenue
- 2860.92
- Selling/ General/ Admin Expenses Total
- 947.39
- Depreciation/ Amortization
- 137.36
- Other Operating Expenses Total
- 6.03
- Total Operating Expense
- 2712.27
- Operating Income
- 148.65
- Net Income Before Taxes
- 93.4
- Net Income
- 59.17
- Diluted Normalized EPS
- 2.95
- Period
- 2019
- Total Assets
- 2637.04
- Total Liabilities
- 1555.91
- Total Equity
- 1081.14
- Tangible Book Valueper Share Common Eq
- 45.77
- Period
- 2019
- Cashfrom Operating Activities
- 278.65
- Cashfrom Investing Activities
- -161.29
- Cashfrom Financing Activities
- -27.29
- Net Changein Cash
- 89.35
- Period
- 2018
- Total Revenue
- 2280.91
- Selling/ General/ Admin Expenses Total
- 730.44
- Depreciation/ Amortization
- 99.95
- Other Operating Expenses Total
- 2.65
- Total Operating Expense
- 2165.02
- Operating Income
- 115.89
- Net Income Before Taxes
- 80.37
- Net Income
- 51.35
- Diluted Normalized EPS
- 2.56
- Period
- 2018
- Total Assets
- 2535.6
- Total Liabilities
- 1499.85
- Total Equity
- 1035.75
- Tangible Book Valueper Share Common Eq
- 43.61
- Period
- 2018
- Cashfrom Operating Activities
- 196.17
- Cashfrom Investing Activities
- -533.76
- Cashfrom Financing Activities
- 315.07
- Net Changein Cash
- -22.22
- Period
- 2024-03-31
- Total Revenue
- 1279.42
- Selling/ General/ Admin Expenses Total
- 249.37
- Depreciation/ Amortization
- 64.79
- Other Operating Expenses Total
- 227.71
- Total Operating Expense
- 1049.64
- Operating Income
- 229.78
- Net Income Before Taxes
- 225.62
- Net Income
- 190.71
- Diluted Normalized EPS
- 9.39
- Period
- 2024-03-31
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 129.63
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023-12-31
- Total Revenue
- 1203.64
- Selling/ General/ Admin Expenses Total
- 254.24
- Depreciation/ Amortization
- 63.19
- Other Operating Expenses Total
- 207.76
- Total Operating Expense
- 987.88
- Operating Income
- 215.76
- Net Income Before Taxes
- 208.58
- Net Income
- 188.02
- Diluted Normalized EPS
- 9.26
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1305.25
- Selling/ General/ Admin Expenses Total
- 255.3
- Depreciation/ Amortization
- 55.27
- Other Operating Expenses Total
- 235.3
- Total Operating Expense
- 1052.41
- Operating Income
- 252.84
- Net Income Before Taxes
- 248.38
- Net Income
- 226.58
- Diluted Normalized EPS
- 11.16
- Period
- 2023-09-30
- Total Assets
- 4786.84
- Total Liabilities
- 2285.12
- Total Equity
- 2501.72
- Tangible Book Valueper Share Common Eq
- 109.41
- Period
- 2023-09-30
- Period
- 2023-06-30
- Total Revenue
- 1233.43
- Selling/ General/ Admin Expenses Total
- 245.38
- Depreciation/ Amortization
- 58.89
- Other Operating Expenses Total
- 235.71
- Total Operating Expense
- 1021.64
- Operating Income
- 211.79
- Net Income Before Taxes
- 205.94
- Net Income
- 183.95
- Diluted Normalized EPS
- 9.06
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1221.59
- Selling/ General/ Admin Expenses Total
- 227.3
- Depreciation/ Amortization
- 56.31
- Other Operating Expenses Total
- 248.76
- Total Operating Expense
- 1002.15
- Operating Income
- 219.44
- Net Income Before Taxes
- 213.53
- Net Income
- 173.14
- Diluted Normalized EPS
- 8.52
- Period
- 2023-03-31
- Total Assets
- 4162.09
- Total Liabilities
- 2030.71
- Total Equity
- 2131.38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 1671.56
- Cashfrom Investing Activities
- -1174.1
- Cashfrom Financing Activities
- 87.74
- Net Changein Cash
- -3.93
- Period
- 2022-12-31
- Total Revenue
- 1128.17
- Selling/ General/ Admin Expenses Total
- 219.73
- Depreciation/ Amortization
- 57.34
- Other Operating Expenses Total
- 220.22
- Total Operating Expense
- 931.09
- Operating Income
- 197.08
- Net Income Before Taxes
- 189.89
- Net Income
- 153.77
- Diluted Normalized EPS
- 7.57
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Narayana Hrudayalaya Technical
Moving Average
SMA
- 5 Day1195.32
- 10 Day1212.13
- 20 Day1217.98
- 50 Day1249.39
- 100 Day1275.1
- 300 Day1205.2
Narayana Hrudayalaya Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 940
- 18.7
- 2.03
- 979.8
- 509.05
- 91359.54
- Fortis Healthcare
- 473.3
- -5.05
- -1.06
- 509.85
- 298
- 35732.17
- Narayana Hrudayalaya
- 1205.35
- 3.35
- 0.28
- 1445.05
- 972.05
- 24480.64
- Dr. Lal Pathlabs
- 2783.2
- 34
- 1.24
- 2889.45
- 1943.2
- 23159.86
- Aster DM Healthcare
- 347.05
- 0.55
- 0.16
- 430.11
- 212.09
- 17275.21
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 81.13
- 10.17
- 10.89
- 15.02
- Fortis Healthcare
- 62.4
- 4.78
- 5.07
- 7.63
- Narayana Hrudayalaya
- 30.78
- 8.42
- 23.44
- 9.72
- Dr. Lal Pathlabs
- 63.24
- 12.23
- 21.32
- 15.99
- Aster DM Healthcare
- 144.09
- 3.87
- 6.24
- 4.26
Narayana Hrudayalaya Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 24-May-24
- Audited Results & Final Dividend
- 14-Feb-24
- Quarterly Results
- 13-Nov-23
- Quarterly Results
- 02-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results & Final Dividend
- 08-Feb-23
- Quarterly Results
- 09-Nov-22
- Quarterly Results
- 08-Aug-22
- Quarterly Results
- 20-May-22
- Audited Results & Final Dividend
- 04-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 04-Aug-23
- 19-May-23
- AGM
- 03-May-23
- 03-Apr-23
- POM
- 30-Aug-22
- 20-May-22
- AGM
- 26-Mar-22
- 21-Feb-22
- POM
- 27-Aug-21
- 31-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-May-24
- 02-Aug-24
- -
- 4
- 19-May-23
- 07-Jul-23
- 07-Jul-23
- 2.5
- 20-May-22
- 23-Aug-22
- 22-Aug-22
- 1
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)